AbbVie Highlights Robust Gastroenterology Portfolio with New Data in Crohn's Disease and Ulcerative Colitis at the UEG Week 2022PRNewsWire • 09/29/22
3 Dividend Aristocrats In Warren Buffett's Secret Portfolio You Can Buy Right NowThe Motley Fool • 09/25/22
The Forces of Beauty® Report from The DREAM Initiative® Reveals Demand for New Standards of Beauty and ImageryPRNewsWire • 09/22/22
Stock Market Could Plunge: These 7 Dividend Aristocrats Can Survive the Fall24/7 Wall Street • 09/21/22
AbbVie Secures Positive CHMP Opinion for Risankizumab (SKYRIZI®) for the Treatment of Adults with Moderate to Severe Crohn's DiseasePRNewsWire • 09/19/22
Calif. Pharmaceutical Companies AbbVie And Bristol Myers Lay Off 360—Here Are The Major U.S. Layoffs This SummerForbes • 09/17/22